MDS Receives U.S. Federal Trade Commission Provisional Regulatory Approval for Sale of MDS Analytical Technologies
Approval a Significant Milestone Toward Close of Transaction

(PressMethod) - MDS Inc. (TSX: MDS - News; NYSE: MDZ - News), a leading provider of products and services to the global life sciences markets, today announced that the Company has received provisional anti-trust approval from the United States Federal Trade Commission (FTC) for the proposed sale of MDS Analytical Technologies to Danaher Corporation (NYSE: DHR - News).

All other requisite regulatory approvals required for the completion of the acquisition have now been received.

The sale of MDS Analytical Technologies to Danaher, which was announced on September 2, 2009, is expected to close before the end of the first calendar quarter of 2010, subject to the satisfaction of conditions to closing.

CONTACT INFORMATION

Email Us

http://

###

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PressMethod. We will be unable to assist you with your inquiry. PressMethod disclaims any content contained in these release.